| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 04/09/2009 | CA2701115A1 N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors |
| 04/02/2009 | US20090088478 Novel compounds as histone deacetylase inhibitors |
| 03/24/2009 | US7507858 3-{4-[Bis-(quinolin-8-ylcarbamoylmethyl)-amino]-phenyl}-N-hydroxy-acrylamide; 4-(2-Hydroxycarbamoyl-vinyl)-N,N-bis-phenylcarbamoylmethyl-benzamide; useful in treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, and neurdegenerative disorders |
| 03/24/2009 | US7507828 Such as quinoline-8-carboxylic acid [5-(2-mercapto-acetylamino)-pentyl]-amide; increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases |
| 03/19/2009 | WO2009035543A1 Dual-acting antihypertensive agents |
| 03/19/2009 | US20090075993 N-[3-(1 -piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine ; increasing vaso-relaxation of a vessel associated with endothelial cells |
| 03/19/2009 | CA2698944A1 Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety |
| 03/17/2009 | US7504537 osteoarthritis or rheumatoid arthritis |
| 03/17/2009 | US7504436 Bioisosteres of actinonin |
| 03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
| 03/05/2009 | WO2009008905A4 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 02/26/2009 | WO2008154402A3 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 02/26/2009 | WO2008147480A3 Hydroxamic acid derivatives of 3-phenyl propionic acids useful as thrapeutic agents for treating anthrax poisoning |
| 02/25/2009 | CN101374801A Histone deacetylase inhibitors for enhancing activity of antifungal agents |
| 02/25/2009 | CN101372470A Oxime ether methoxy acrylate compound having disinsection and sterilization activity |
| 02/24/2009 | US7495022 α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| 02/17/2009 | CA2416769C Process for preparing discodermolide and analogues thereof |
| 02/12/2009 | US20090042992 Polymorphs of suberoylanilide hydroxamic acid |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/11/2009 | CN101365709A Functionalised nanoparticles, their production and use |
| 02/03/2009 | US7485750 novel compound showing antioxidant effects,collagen biosynthesis ability and skin pore contraction effects without showing instability; for preventing skin aging; N-(4-((hydroxycarbamoyl)methyl)phenyl)-3,4-dibutoxy benzamide |
| 01/29/2009 | WO2009012656A1 Inhibitors for matrix metalloproteinases, pharmaceutical compositions containing them and their uses |
| 01/28/2009 | CN101356152A Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
| 01/22/2009 | US20090023786 Histone Deacetylase Inhibitor Prodrugs |
| 01/22/2009 | US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives |
| 01/20/2009 | CA2364944C C16 unsaturated fp-selective prostaglandins analogs |
| 01/15/2009 | WO2009008905A1 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning |
| 01/15/2009 | WO2008147480A8 Hydroxamic acid derivatives of 3-phenyl propionic acids useful as thrapeutic agents for treating anthrax poisoning |
| 01/13/2009 | US7476740 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions |
| 01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 01/07/2009 | EP2010168A2 Histone deacetylase inhibitors |
| 12/25/2008 | US20080319206 Process for Preparing Protected Amidines |
| 12/24/2008 | WO2008154905A2 Modifications of the histone deacetylase inhibitor suberoylanilide hydroxamic acid |
| 12/18/2008 | WO2008154642A2 Antibacterial agents |
| 12/18/2008 | WO2008154382A1 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 12/18/2008 | US20080312324 Treatment of lung cells with histone deacetylase inhibitors |
| 12/18/2008 | US20080312186 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 12/18/2008 | CA2726734A1 Hdac inhibitor ms-275 and aromatase inhibitors for the treatment of cancer |
| 12/18/2008 | CA2691987A1 Antibacterial agents |
| 12/17/2008 | EP1542968B1 Process for preparing intermediates |
| 12/16/2008 | US7465719 e.g. 4-{[(Benzyloxy)amino]carbonyl}phenyl 1-(4-methoxyphenyl)cyclohexanecarboxylate; histone deacetylase inhibitor; anticarcinogenic, antiproliferative agent; neurodegenerative diseases; bactericide; psoriasis, osteoarthritis; rheumatoid arthritis, malaria, protozoal infection, Alzheimer's; Parkinson's |
| 12/16/2008 | CA2302937C Method for producing (hetero)aromatic hydroxylamines |
| 12/10/2008 | EP1856035B1 Process for preparaing protected amiidines |
| 12/04/2008 | WO2008147480A2 Hydroxamic acid derivatives of 3-phenyl propionic acids useful as thrapeutic agents for treating anthrax poisoning |
| 12/03/2008 | CN100439334C Process for preparing intermediates |
| 11/26/2008 | CN101311165A Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 11/26/2008 | CN100436425C Fused imidazolium derivatives |
| 11/25/2008 | US7456219 Polymorphs of suberoylanilide hydroxamic acid |
| 11/20/2008 | WO2008097459A3 Dual-acting antihypertensive agents |
| 11/13/2008 | WO2008136976A2 Compounds for treating proliferative disorders |
| 11/11/2008 | US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis |
| 11/05/2008 | CN100430052C Cathepsin cysteine protease inhibitors |
| 11/04/2008 | US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 10/30/2008 | US20080269221 Antibacterial agents |
| 10/30/2008 | US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease |
| 10/29/2008 | EP1587784A4 Bisaminophenyl-based curatives and amidine-based curatives and cure accelerators for perfluoroelastomeric compositions |
| 10/28/2008 | US7442793 Enzyme inhibitors as bactericides for infections and enzyme inhibitors |
| 10/21/2008 | US7439396 Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors |
| 10/16/2008 | WO2008122115A1 Inhibitors of histone deacetylase |
| 10/16/2008 | US20080255221 Novel hydroxamates as therapeutic agents |
| 10/16/2008 | US20080255214 Novel hydroxamates as therapeutic agents |
| 10/16/2008 | US20080255182 Certain chemical entities, compositions, and methods |
| 10/16/2008 | CA2683557A1 Inhibitors of histone deacetylase |
| 10/15/2008 | EP1979365A2 Functionalised nanoparticles, their production and use |
| 10/15/2008 | EP1660437B1 Hydroxamic acid derivatives and the method for preparing thereof |
| 10/15/2008 | CN101287731A Dioxazine- and oxdiazine-substituted arylamides |
| 10/09/2008 | US20080249179 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time |
| 10/07/2008 | CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 10/02/2008 | WO2008025965A3 Retinoid compounds and their use |
| 10/01/2008 | EP1973872A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 09/25/2008 | WO2008115153A1 N-heterocyclic carbene (nhc) catalyzed synthesis of hydroxamic acids |
| 09/18/2008 | US20080228005 Polymorphs of suberoylanilide hydroxamic acid |
| 09/18/2008 | US20080227862 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time |
| 09/17/2008 | CN101265226A Compounds and methods for delivery of prostacyclin analogs |
| 09/10/2008 | CN101259120A Methods of inducing terminal differentiation |
| 09/04/2008 | WO2008104755A1 Succinate derivatives and their therapeutic use |
| 09/04/2008 | US20080213347 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 09/03/2008 | EP1963262A2 N-hydroxyamide derivatives possessing antibacterial activity |
| 09/03/2008 | EP1963258A2 Histone deacetylase inhibitors for enhancing activity of antifungal agents |
| 09/03/2008 | CN101255124A Cinnamide histone deacetylase inhibitor and preparation method thereof |
| 09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 09/02/2008 | US7420078 Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof |
| 08/27/2008 | CN101252838A Novel hydroxamic acid containing amino acid derivatives |
| 08/26/2008 | US7417022 Amino acid for deliverying active materials; bioavailability |
| 08/21/2008 | US20080200525 Pesticidally active ketone and oxime derivatives |
| 08/21/2008 | DE102007008655A1 Siderophor-Metall-Komplexe als Bleichkatalysatoren Siderophore-metal complexes as bleach catalysts |
| 08/20/2008 | CN101245035A Hydroxamic acid derivant, preparation method and antineoplastic application |
| 08/19/2008 | CA2333377C Mineral collector compositions of fatty hydroxamic acid in admixture with an oil and process of making same |
| 08/14/2008 | WO2008097459A2 Dual-acting antihypertensive agents |
| 08/14/2008 | US20080194692 Polymorphs of suberoylanilide hydroxamic acid |
| 08/13/2008 | CN101243128A Catalyst for making fluoroelastomer compositions and methods of using the same |
| 08/12/2008 | US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/07/2008 | WO2008094592A1 Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/06/2008 | EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/05/2008 | US7408081 Process for treating an aqueous medium containing cyclohexanone oxime and cyclohexanone |
| 08/05/2008 | US7407988 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |